openPR Logo
Press release

North America Psychedelic Drugs Market Undertakes Strapping Growth By 2020 With Johnson & Johnson, Jazz Pharmaceuticals, Celon Pharma SA, COMPASS, NeuroRX, Hikma Pharmaceuticals

11-19-2020 11:49 AM CET | Health & Medicine

Press release from: Data Bridge Market Research Pvt. Ltd.

North America Psychedelic Drugs Market

North America Psychedelic Drugs Market

Psychedelic Drugs Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales promotion efforts. The market report is a professional yet exhaustive study on the current state for the market. This world class market research report is a vital document in planning business objectives or goals. The credible market report is a window to the industry which talks about what market definition, classifications, applications, engagements and market trends are. While formulating this Psychedelic Drugs Market analysis report, client business competence is understood adeptly to identify tangible growth opportunities.

Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-psychedelic-drugs-market

The wide ranging Psychedelic Drugs Market report evaluates CAGR value fluctuation during the forecast period of 2021-2028 for the market. All the data of research and analysis are mapped in an actionable model, with strategic recommendations from the experts. Base year for calculation in the report is considered as 2020 while the historic year is 2019 which will tell how the Psychedelic Drugs Market is going to act upon in the forecast years by giving information about the several market insights. Lastly, the large scale report makes some important proposals for a new project of the market before evaluating its feasibility.

Market Analysis and Insights: North America Psychedelic Drugs Market

North America psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 15.8% in the forecast period of 2020 to 2027 and expected to reach USD 6,846.68 million by 2027. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth.

The major players covered in the North America Psychedelic Drugs Market report are Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma SA, COMPASS, usonainstitute.org, Develco pharma schweiz ag, Doughlas pharmaceuticals limited, NeuroRX, Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, LLC., AVADEL PHARMACEUTICALS, PLC among other players in North America DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-psychedelic-drugs-market

Psychedelics have seen a surge in popularity over the past decade. Psychedelics have been familiarly involved with healing and mental treatment practices with mind-altering substances since the dawn of time. However, research studies have generally stopped since psychedelic care was banned in the late 1960s. After being relegated to the margins of sincere scientific examination for about five decades, growing researchers and scientists are exploring the therapeutic value of psychedelic drugs and compounds that could be a new treatment option for people with depression.

Department of Neuroscience, faculty of medicine, Norwegian University of Science and Technology, Trondheim, Norway, conducted a study in the United States “Over 30 million psychedelic users in the United States”.

The promising results of psychedelic drugs have increased the use of psychedelic drugs in the United States, which leads to an increasing demand for psychedelic drugs in the United States, so these factors are functioning as drivers for the North America psychedelic drugs market.

This psychedelic drugs market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Psychedelic Drugs Market Scope and Market Size

Psychedelic drugs market is segmented on the basis of source, type, application, route of administration, drugs, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of source, the market is segmented into synthetic and natural. In 2020, synthetic segment holds major share in the market as all available drugs are derived from synthetic origin.
On the basis of type, the market is segmented into dissociatives, empathogens, and serotonergic (classical psychedelic drugs). In 2020, dissociative segment holds largest share in the psychedelic drugs market, as Xyrem (Sodium Oxide) is the only approved drug available in the market for the treatment of narcolepsy.
On the basis of application, the market is segmented into narcolepsy, treatment-resistant depression, post-traumatic stress disorder (PTSD), major depressive disorder, others. In 2020, narcolepsy dominates in the psychedelic drugs market as gamma hydroxybutyric acid (GHB) derivative is the predominantly used psychedelic drug and this drug has been approved for narcolepsy.
On the basis of route of administration, the market is segmented into oral, intranasal, parenteral, others. In 2020, oral drug segment dominates the psychedelic drugs market, as Xyrem is the most branded drug available in the market in oral dosage forms. In addition, patient adherence is very important in the symptomatic treatment of the disease. Oral administration of the drug is very convenient for patients compared to other forms.
On the basis of drugs, the market is segmented into gamma hydroxybutyric acid (GHB), ketamine, 3, 4-methylenedioxymethamphetamine (ecstasy), psilocybin. In 2020, gamma hydroxybutyric acid (GHB) dominates the market as Xyrem is primarily a psychedelic drug and falls into this category.
On the basis of end user, the market is segmented into hospitals, speciality clinic, research organisation, others. In 2020, hospitals segment is dominating the market as most drugs are administered by physician supervision.
On the basis of distribution channel, the market is segmented into hospital pharmacy, compounding pharmacy, others. In 2020, hospital pharmacy segment has the highest market share because these drugs treat more patients in hospitals which have increased the demand for hospital pharmacy.

Increasing R & D Activities in Psychedelic Drugs is Creating New Opportunities for Manufacturers in Psychedelic Drugs Market

Psychedelic drugs market also provides you with detailed market analysis for every country growth in aesthetic industry with psychedelic drugs sales, impact of advancement in the psychedelic drugs and changes in regulatory scenarios with their support for the psychedelic drugs market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Psychedelic Drugs Market Share Analysis

Psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to psychedelic drugs market.

Many product launch and developments are also initiated by the companies worldwide which are also accelerating the psychedelic drugs market.

For instance,

In January 2020, COMPASS received the U.S Patent for COMP 360, a formulation of psilocybin. Helps the patenting company to develop a developmental condition for treating depression. This is a novel product because the patent increases their revenue.
In January 2019, Douglas Pharmaceuticals Ltd launched a clinical trial for phase 2 of ketamine for the treatment of depression – for patients with depression. Helping the company launch a new product in the clinical trial market.

Clinical study data sets, authorization, collaboration, joint ventures and other strategies by the market players is enhancing the market in the psychedelic drugs market also provides the benefit for organisation to improve their offering for psychedelic drugs.

Customization Available: North America Psychedelic Drugs Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Some of the Major Highlights of TOC covers:
Chapter 1: Methodology & Scope
Definition and forecast parameters
Methodology and forecast parameters
Data Sources
Chapter 2: Executive Summary
Business trends
Regional trends
Product trends
End-use trends
Chapter 3: Psychedelic Drugs Market Industry Insights
Industry segmentation
Industry landscape
Vendor matrix
Technological and innovation landscape
Chapter 4: Psychedelic Drugs Market, By Region
Chapter 5: Company Profile
Business Overview
Financial Data
Product Landscape
Strategic Outlook
SWOT Analysis

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-psychedelic-drugs-market

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Psychedelic Drugs Market Undertakes Strapping Growth By 2020 With Johnson & Johnson, Jazz Pharmaceuticals, Celon Pharma SA, COMPASS, NeuroRX, Hikma Pharmaceuticals here

News-ID: 2190680 • Views: 359

More Releases from Data Bridge Market Research Pvt. Ltd.

Wearable Skin Patch Market 2020-2026 Going to Acquire Bigger Piece of Industry | …
A transparent research method has been accomplished with the right tools and techniques to make this Wearable Skin Patch Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter’s Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions,
Veterinary Diagnostics Market 2020-2026 Going to Acquire Bigger Piece of Industr …
A transparent research method has been accomplished with the right tools and techniques to make this Veterinary Diagnostics Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter’s Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements,
Veterinary Clostridium Vaccine Market 2020-2026 Going to Acquire Bigger Piece of …
A transparent research method has been accomplished with the right tools and techniques to make this Veterinary Clostridium Vaccine Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter’s Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions,
Urgent Care Market 2020-2026 Going to Acquire Bigger Piece of Industry || Leadin …
A transparent research method has been accomplished with the right tools and techniques to make this Urgent Care Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter’s Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements,

All 5 Releases


More Releases for Psychedelic

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 bil …
A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings. For additional details, please visit https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html The report features an extensive study of the current market landscape, offering an informed
Psychedelic Drugs Market 2020 Insights, Industry Growth Factors, Applications, D …
This Psychedelic Drugs Market report includes a wide-ranging evaluation of the market’s growth prospects and restrictions. The Psychedelic Drugs Market report provides estimations about the growth rate and the market value in ABC industry based on market dynamics and growth inducing factors. Global Psychedelic Drugs Market report studies the industry abilities for each geographical region based on the customer purchasing patterns, macroeconomic parameters, development rate, and market demand and supply
Psychedelic Drugs Market Growth Powered with Latest Development Scenario & Influ …
DBMR announces the release of the report “Psychedelic Drugs Market” Size, Share & Trends Analysis Report By 2027. Psychedelic Drugs Market is 2020 Research Report on Global professional and comprehensive report on the Psychedelic Drugs Market. The report monitors the key trends and market drivers in the current scenario and offers on the ground insights. This report highlights key market dynamics of Psychedelic Drugs industry and covers historic data, present market trends,
Psychedelic Drugs Market to Show Tremendous Growth by 2027 | Leading Players-COM …
Global Psychedelic Drugs Market research report involves a key data and information about the market, emerging trends, product usage, motivating factors for customers and competitors, restraints, brand positioning, and customer behaviour, which is of utmost importance when it comes to achieving a success in the competitive marketplace. Thus, the report deals with plentiful aspects of the industry. This market report provides with CAGR value fluctuation during the forecast period of
What's Driving The Psychedelic Drugs Market Trends ? COMPASS, Abbott, Boston Sci …
A market research report such as this Psychedelic Drugs Market report is absolutely essential in today's highly competitive world, wherein businesses need to collect data and information to tap emerging opportunities and to position themselves outstandingly in the market. A good market research report has information on almost everything : be it about prospective clients, segmentation of market or growth opportunities. Therefore, DBMR team has generated this market report in
Global Psychedelic Drugs Market - Industry Trends and Forecast to 2026
Global psychedelic drugs market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Growing prevalence of depression worldwide and increase in special designation from the regulatory authorities to the company to expedite the development process are the key factors for market growth. Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-psychedelic-drugs-market Few of the major competitors currently working in the global psychedelic drugs market are COMPASS, The Emmes